Literature DB >> 10672986

Rewarding properties of testosterone in intact male mice: a pilot study.

M T Arnedo1, A Salvador, S Martinez-Sanchis, E Gonzalez-Bono.   

Abstract

The present study examined the rewarding properties of 4-androsten-17beta-ol-3-one testosterone in intact male mice using the conditioned place preference (CPP) technique. In Experiment 1, the pharmacokinetics of 0.8 and 1.2 mg/kg of testosterone were studied to determine the most appropriate temporal interval to test behavior. Additionally, the locomotor activity was recorded to control a possible interfering effect on CPP. The maximum testosterone concentration was registered at 45 min of administration, and no effects on activity were found. In Experiment 2, three groups of male OF-1 mice received four pairings of the least-preferred compartment with testosterone (0.8, 1, or 1.2 mg/kg, SC) for 30 min. On alternate days the preferred compartment was paired with vehicle for 30 min. The control group received vehicle in both compartments. No significant differences between groups were found in the time spent in the drug-paired compartment. However, when separate analyses were performed in conjunction with the color of the drug-paired compartment. CPP was observed only in animals pairing testosterone/black compartment. These results suggest that rewarding properties of testosterone treatment can be observed in male mice; these effects probably being dependent on the environmental cues used as conditioned stimuli.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10672986     DOI: 10.1016/s0091-3057(99)00189-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  24 in total

1.  The testosterone metabolite 3α-diol enhances female rat sexual motivation when infused in the nucleus accumbens shell.

Authors:  Eliana L Sánchez Montoya; Lizaida Hernández; Jennifer L Barreto-Estrada; José G Ortiz; Juan Carlos Jorge
Journal:  J Sex Med       Date:  2010-11       Impact factor: 3.802

Review 2.  Adolescents and androgens, receptors and rewards.

Authors:  Satoru M Sato; Kalynn M Schulz; Cheryl L Sisk; Ruth I Wood
Journal:  Horm Behav       Date:  2008-02-13       Impact factor: 3.587

3.  Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2009-04-01       Impact factor: 4.492

Review 4.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

Review 5.  Anabolic steroid abuse and dependence.

Authors:  Kirk J Brower
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

6.  Testosterone reinforcement: intravenous and intracerebroventricular self-administration in male rats and hamsters.

Authors:  Ruth I Wood; Luke R Johnson; Lucy Chu; Christina Schad; David W Self
Journal:  Psychopharmacology (Berl)       Date:  2003-10-14       Impact factor: 4.530

Review 7.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

Review 8.  Anabolic-androgenic steroid dependence? Insights from animals and humans.

Authors:  Ruth I Wood
Journal:  Front Neuroendocrinol       Date:  2008-01-03       Impact factor: 8.606

Review 9.  Anabolic-androgenic steroid dependence: an emerging disorder.

Authors:  Gen Kanayama; Kirk J Brower; Ruth I Wood; James I Hudson; Harrison G Pope
Journal:  Addiction       Date:  2009-12       Impact factor: 6.526

Review 10.  Reflexive testosterone release: a model system for studying the nongenomic effects of testosterone upon male behavior.

Authors:  John G Nyby
Journal:  Front Neuroendocrinol       Date:  2007-10-01       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.